Heart artery care in hemophilia study
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.
This study uses a special CT scan to check for heart artery disease in men with hemophilia. It aims to better understand heart risks in this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male and at least 45 years old (no upper age limit).
- You must have hemophilia A or B with a clotting factor (VIII or IX) level below 40% of normal.
- You must be willing and able to give your permission to join the study and understand English.
- You must be able to attend for scans and tests at the hospital.
- You cannot have severe kidney disease or any known allergies to CT contrast dye (the dye used for heart scans).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study looks at how two different hemophilia A treatments affect bone health over time. It tests if one medicine is better at keeping bones strong than the other.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study looks at people with coronary artery disease (narrowed or blocked heart arteries) to see how different imaging and function tests can help predict outcomes. If you've had a heart procedure or test showing blockages, you might be eligible.
This study evaluates the heart health of people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels. By participating, you help doctors understand how HHT affects the heart, which may improve future care.
This study uses ultrasound to check the health of your joints. It aims to see if people with mild hemophilia have joint problems even without frequent bleeding, which could help guide future treatment.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.